RxDoctor Payments Data

Mark Micciche, DPM

Podiatrist · Hawley, PANPI 1336195031

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,614 of the $7,009 with a category attached, or 65.8%. 15 manufacturers reported payments, led by Stryker at 50.9% of the total.

$7,009in general payments, 2019–2025

Across 128 payments — averaging $54.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$4K
  • Arthrex$1K
  • Smith+Nephew$943
  • Novus Surgical Consultants$523
  • Treace Medical Concepts, Inc.$220
  • Novus Surgical Solutions LLC$179
  • plus $471 from 9 others

What the payments were for

  • Travel & lodging$1,90427%
  • Food & beverage$4,61466%
  • Education$4927%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker35$3,567
Arthrex8$1,106
Smith+Nephew52$943
Novus Surgical Consultants3$523
Treace Medical Concepts, Inc.3$220
Novus Surgical Solutions LLC2$179
Organogenesis Inc.9$138
Integra Lifesciences Corporation5$122
Acell, Inc.2$47
KCI USA, Inc.2$47
Melinta Therapeutics, LLC2$36
Bioventus LLC2$29
Linvatec Corporation1$23
Paragon 28, Inc.1$19
Amgen1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,009 in reported general payments places this provider in the 85th percentile of 445 podiatrist providers in Pennsylvania.

See all podiatrist providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$82,567
Medicare patients
245
Services billed
1,014

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox42$778
Diclofenac Sodium20$755
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort14$682
Pregabalin61$585
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip24$396
Ammonium Lactate20$310
Ketoconazole11$241
Mupirocin14$206
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen40$190
Methylprednisolone18$140
Gabapentin13$68

Paid to pharmacies, not to this prescriber.

Other podiatrist in Hawley

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →